Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 10/20 | 0.54 |
| ▸ | MMP9 | P14780 | 10/20 | 0.54 |
| ▸ | MMP12 | P39900 | 3/20 | 0.54 |
| ▸ | MMP3 | P08254 | 3/20 | 0.52 |
| ▸ | MMP13 | P45452 | 3/20 | 0.52 |
| ▸ | MMP14 | P50281 | 4/20 | 0.51 |
| ▸ | MMP1 | P03956 | 4/20 | 0.51 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8229795 | 0.88 | MMP2 (0.54) | MMP2MMP9MMP12MMP3MMP13 | |
| SCHEMBL317130 | 0.77 | MMP9 (0.59) | MMP2MMP9MMP12MMP3MMP13 | |
| SCHEMBL315481 | 0.75 | MMP2 (0.60) | MMP2MMP9MMP12MMP3MMP13 | |
| SCHEMBL7230599 | 0.69 | MMP2 (1.00) | MMP2MMP9MMP3MMP13MMP14 | |
| SCHEMBL7073583 | 0.69 | MMP2 (0.56) | MMP2MMP9MMP3MMP13MEN1 | |
| SCHEMBL7956006 | 0.67 | MMP2 (0.64) | MMP2MMP9MMP3MMP13MMP14 | |
| SCHEMBL1782200 | 0.67 | MMP2 (1.00) | MMP2MMP9MMP12MMP3MMP13 | |
| SCHEMBL323934 | 0.67 | MMP2 (0.67) | MMP2MMP9MMP12MMP3MMP13 | |
| SCHEMBL8231858 | 0.67 | MMP2 (0.60) | MMP2MMP9MMP12MMP14MEN1 | |
| SCHEMBL9113979 | 0.67 | RAB9A (0.69) | MEN1KMT2AHSD17B10CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8093386-B2 | Thioaryl substituted inhibitors of zinc proteases and their use | BRACCO IMAGING S.P.A (IT) | 2012-01-10 | — | — | US | disclosed |
| US-20090239829-A1 | THIOARYL SUBSTITUTED INHIBITORS OF ZINC PROTEASES AND THEIR USE | BRACCO IMAGING SPA (IT) | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090239829-A1 | THIOARYL SUBSTITUTED INHIBITORS OF ZINC PROTEASES AND THEIR USE | SERPINB1, ZFX, MMP2 | MMP2 3/4885MMP9 8/4885MMP12 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.